Quality-of-life meta-analysis: why treat it differently?

Comment

Jeff A Sloan. J Clin Oncol. 2003.

. 2003 Apr 1;21(7):1422.

doi: 10.1200/JCO.2003.99.037.

No abstract available

Comment on

Beyond the development of quality-of-life instruments: where do we go from here?
Levine MN, Ganz PA. Levine MN, et al. J Clin Oncol. 2002 May 1;20(9):2215-6. doi: 10.1200/JCO.2002.20.9.2215. J Clin Oncol. 2002. PMID: 11980989 No abstract available.
Do quality-of-life randomized clinical trials support clinicians in their decision-making?
Efficace F, Bottomley A. Efficace F, et al. J Clin Oncol. 2002 Oct 1;20(19):4126-7; author reply 4127. doi: 10.1200/JCO.2002.99.117. J Clin Oncol. 2002. PMID: 12351614 No abstract available.